Inari Medical IncNASDAQ:NARI
- LAST PRICE51.9200
- TODAY'S CHANGE (%)0.8900 (1.7441%)
- Bid / Lots50.0000/ 10
- Ask / Lots52.7500/ 2
- Open / Previous Close51.0100 / 51.0300
- Day Range
- 52 Week Range
- Volume287,786
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NARI |
|---|---|---|
| 09:32 ET | 3907 | 51.01 |
| 09:33 ET | 900 | 51.17 |
| 09:37 ET | 242 | 51.115 |
| 09:39 ET | 200 | 51.055 |
| 09:44 ET | 400 | 51.055 |
| 09:46 ET | 411 | 51.065 |
| 09:48 ET | 600 | 51.13 |
| 09:50 ET | 1200 | 51.04 |
| 09:51 ET | 400 | 51.18 |
| 09:53 ET | 808 | 51.125 |
| 09:55 ET | 100 | 51.25 |
| 10:00 ET | 100 | 51.15 |
| 10:02 ET | 2500 | 51.38 |
| 10:04 ET | 200 | 51.35 |
| 10:06 ET | 451 | 51.31 |
| 10:08 ET | 1200 | 51.39 |
| 10:11 ET | 641 | 51.31 |
| 10:13 ET | 300 | 51.39 |
| 10:15 ET | 1149 | 51.37 |
| 10:20 ET | 900 | 51.335 |
| 10:22 ET | 600 | 51.5 |
| 10:26 ET | 100 | 51.45 |
| 10:29 ET | 100 | 51.41 |
| 10:31 ET | 100 | 51.47 |
| 10:33 ET | 3677 | 51.28 |
| 10:36 ET | 117 | 51.265 |
| 10:38 ET | 100 | 51.32 |
| 10:40 ET | 1700 | 51.28 |
| 10:42 ET | 934 | 51.22 |
| 10:44 ET | 457 | 51.08 |
| 10:45 ET | 1900 | 50.995 |
| 10:47 ET | 310 | 51.05 |
| 10:49 ET | 1289 | 51.165 |
| 10:51 ET | 1800 | 51.24 |
| 10:54 ET | 1653 | 51.2454 |
| 10:56 ET | 100 | 51.31 |
| 11:02 ET | 672 | 51.34 |
| 11:03 ET | 5376 | 51.26 |
| 11:05 ET | 1108 | 51.3 |
| 11:07 ET | 200 | 51.38 |
| 11:09 ET | 6767 | 51.6 |
| 11:14 ET | 1779 | 51.41 |
| 11:18 ET | 300 | 51.3675 |
| 11:20 ET | 479 | 51.265 |
| 11:21 ET | 300 | 51.33 |
| 11:25 ET | 1400 | 51.45 |
| 11:27 ET | 100 | 51.455 |
| 11:30 ET | 130 | 51.4016 |
| 11:32 ET | 400 | 51.395 |
| 11:34 ET | 1983 | 51.33 |
| 11:36 ET | 900 | 51.275 |
| 11:38 ET | 540 | 51.32 |
| 11:39 ET | 776 | 51.28 |
| 11:43 ET | 300 | 51.31 |
| 11:45 ET | 100 | 51.305 |
| 11:48 ET | 293 | 51.34 |
| 11:50 ET | 2433 | 51.34 |
| 11:52 ET | 2600 | 51.3 |
| 11:54 ET | 100 | 51.3 |
| 11:56 ET | 2383 | 51.51 |
| 11:57 ET | 589 | 51.5 |
| 12:01 ET | 5400 | 51.58 |
| 12:03 ET | 200 | 51.505 |
| 12:06 ET | 300 | 51.54 |
| 12:08 ET | 1034 | 51.505 |
| 12:10 ET | 400 | 51.44 |
| 12:12 ET | 456 | 51.39 |
| 12:14 ET | 1201 | 51.39 |
| 12:26 ET | 100 | 51.4 |
| 12:28 ET | 3670 | 51.45 |
| 12:30 ET | 5125 | 51.38 |
| 12:32 ET | 1500 | 51.385 |
| 12:33 ET | 600 | 51.385 |
| 12:35 ET | 600 | 51.39 |
| 12:37 ET | 3929 | 51.44 |
| 12:39 ET | 264 | 51.43 |
| 12:42 ET | 900 | 51.47 |
| 12:46 ET | 506 | 51.52 |
| 12:48 ET | 1871 | 51.58 |
| 12:50 ET | 1608 | 51.67 |
| 12:51 ET | 1625 | 51.63 |
| 12:53 ET | 900 | 51.59 |
| 12:55 ET | 8952 | 51.67 |
| 12:57 ET | 1698 | 51.75 |
| 01:00 ET | 94168 | 51.92 |
Nov 19, 2024
Nov 13, 2024
Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
1:09PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 6, 2024
Inari Medical to Participate in the Jefferies London Healthcare Conference, from 4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:05PM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 1, 2024
Notice to Long-Term Inari (NARI) Shareholders: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf, from 8:09AM ET on Friday Nov 01, 2024 by Dow Jones
8:09AM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inari Medical Inc | 3.0B | -38.4x | --- |
Warby Parker Inc | 2.8B | -82.5x | --- |
Neogen Corp | 3.1B | -130.5x | --- |
UFP Technologies Inc | 2.5B | 46.1x | +24.81% |
LivaNova PLC | 2.8B | 123.3x | --- |
Novocure Ltd | 1.9B | -14.4x | --- |
Company Information
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
Contact Information
- Headquarters
- 6001 Oak Canyon, Suite 100IRVINE, CA, United States 92618
- Phone
- 949-923-4747
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Donald Milder
- President, Chief Executive Officer, Director
- Andrew Hykes
- Chief Financial Officer
- Kevin Strange
- Chief Medical Officer
- Thomas Tu
- Director
- William Hoffman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $574.5M |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | $-1.35 |
Book Value | $8.05 |
P/E Ratio | -38.4x |
Price/Sales (TTM) | 5.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
